CD34+-selected stem cell boost is safe and highly effective for refractory PGF after allo-HSCT, including in haploidentical recipients and those who have failed TPO-RAs.
Y. He, Lin-Wei Shi, R. Ma et al.· Haematologica· 0 citations
Summary Relapse remains the main cause of death in acute myeloid leukemia (AML), and T cell exhaustion is related to relapse in both non-allografting and allografting settings. However, differences in exhausted T cells (Tex) across different disease contexts remain incompletely understood. We performed single-cell RNA...
Myelodysplastic syndromes (MDS) are clonal disorders with high risk of progression to acute myeloid leukemia (AML). Allogeneic haematopoietic stem cell transplantation (allo‐HSCT), including haploidentical HSCT (haplo‐HSCT), is the only curative option. Age‐stratified selection of conditioning regimens based on organ r...
Ning Wu, Meng Lv, Xiao-Dong Mo et al.· Hematological Oncology· 0 citations
Objective Cytomegalovirus (CMV) infection can cause severe morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Letermovir is recommended as CMV prophylaxis for allo-HSCT recipients. This study aimed to further confirm the efficacy of letermovir prophylaxis in d...
Yi Xia, Qi Wen, Jing Liu et al.· Frontiers in Immunology· 0 citations
BACKGROUND
High-dose cyclophosphamide (Cy)-related cardiotoxicity (CT) during transplant conditioning in patients with severe aplastic anemia (SAA) is a life-threatening complication.
OBJECTIVE
To evaluate the efficacy and safety of a modified conditioning regimen to reduce CT in pediatric SAA.
METHODS
We conducted...
Feng Zhang, P. Suo, Guan-Hua Hu et al.· Transplantation and Cellular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.